Asian Pacific Association for the Study of the Liver
Single Topic Conference
Focus on the Virus Hepatitis B
3-6 October 2015 Yerevan, Armenia
Home page

PRESENTATIONS APASL STC

Focus on the Virus Hepatitis B
3-6 October, Yerevan, Armenia

  04.10.2015
Changing HBV Epidemiology in ASIA
Sang Hoon AHN, MD, PhD 
THE CHANGING EPIDEMIOLOGY
OF HBV IN MONGOLIA
OIDOV BAATARKHUU MD., PhD 
Changing epidemiology and control of hepatitis B in Europe
Pierre Van Damme, MD, PhD 
Hepatitis B Virus Infection in US
W. Ray Kim, MD 
Epidemiology of HBV Infection in Russia
Vladimir Chulanov 
Epidemiology of HBV-infection in Ukraine
Moroz L.V.
HBV in BELARUS
Karpov I.A., MD, PhD, DSc
Danilau D.E., MD, PhD
Litvinchuk D.V. 
HBV infection in Georgia
Some Aspects of Epidemiology
David Metreveli MD PhD  
Epidemiology of HBV infection in Kazakhstan
Prof. Alexander V. Nersesov, MD, ScD
HBV INFECTION in ARMENIA
Gayane Melik-Andreasyan MD, PhD, ScD, Professor
Viral Hepatitis in Armenia
Hasmik Ghazinyan MD PHD 
How to Apply the Updates on HBV Guidelines
APASL and WHO
M. Omata, O. Yokosuka, Japan 
HBV: Genotypes Serotyping, Core and PreCore Mutations
Robert G Gish MD
The host–pathogen interaction during HBV infection
Tigran K. Davtyan, PhD 
Ocuult Hepatitis B Infection
Dr. Saeed Hamid
Hepatitis B Virus Infection and Hepatocellular Carcinoma
W. Ray Kim, MD 
Acute on Chronic Liver Failure
Dr. S K Sarin 
HBV: ACLF - Course and Therpay
Dr. S K Sarin 
The Role of Non-Invasive Markers and Imaging
in Staging Liver Disease in Chronic HBV Infection
Professor Salimur Rahman 
Hepatitis B:
Treatment Indications and Therapeutic End-Points
Dr. S K Sarin 
HBV Treatment a focus on sAg and cccDNA
Robert G Gish MD
  05.10.2015
“Impact of the New Player, HBsAg on Clinical Management”
Prof. ALAAELDIN IBRAHIM (M.D) 
Monitoring and Management of Nucleos(t)ide Analogues Failures
Vladimir Chulanov 
Risk Factors for Hepatocellular Carcinoma Development
during Nucleotide Analogue Treatment for Chronic Hepatitis B
Osamu Yokosuka, Akinobu Tawada
Makoto Arai, Tatsuo Kanda  
Management of CHB patients with Decompensated Cirrhosis
CHIA-YEN DAI M.D. Ph.D 
Can cirrhosis be really reversible
Pierre Bedossa 
Management of Chronic Hepatitis B
in the Immunosuppressed Patients
Sargsyants Narina, MD, PhD 
Management of Hepatitis B in Children
Dr. Mamun Al Mahtab 
Hepatitis B and Pregnancy
Hasmik Ghazinyan MD PHD 
Management of Chronic Hepatitis B co-Infected
patients HBV/HCV and HBV/HIV
Violeta Sargsyan MD, PhD 
Management of Chronic Hepatitis B
in Patients with Renal Failure
UNUSUAL CASE OF HIGHLY REPLICATIVE
HEPATITIS B VIRUS INFECTION WITH
EXTRAHEPATIC MANIFESTATIONS
Sargsyants Narina, MD, PhD 
Hepatitis B reactivation after pagylated interferon plus
ribavirin in chronic HBV/HCV coinfected Taiwanese patient
Prof. Chia-Yen Dai 
A Case of HBV related Chronic Liver
Disease Presenting as Acute Hepatitis
Dr. Mamun Al Mahtab 
Management of chronic hepatitis D (with case presentation)
Prof. Alexander V. Nersesov, MD, ScD 
WHO Policy on Viral Hepatitis B
Antons Mozalevskis  
HBV Treatment - Beyond Guidelines
Manoj Kumar Sharma 
Хроническая HBV-инфекция: новые возможности лечения
Богомолов П.О. 
Development of novel therapeutic hepatitis B
Gerardo Guillen 
HBV Treatment Endpoints and Research
Directions for (Functional) Cure
Robert G Gish MD
HBV case discussion
Robert G Gish MD 

  • ASIAN PACIFIC ASSOCIATION FOR STUDY OF THE LIVER